glp 1 or sglt2 Inhibitors and GLP-1 Receptor Agonists in Kidney Transplantation: A Systematic Review and Meta-Analysis Cardiovascular benefits of SGLT2 inhibitors
Description
Glucagon-like peptide-1 receptor agonists (GLP-1RAs), such as semaglutide, are widely used in the treatment of metabolic disorders, including type 2 diabetes (T2D) and obesity
For best results, take with a meal
WW International is launching a platform that integrates its wellness program with GLP-1 drugs
Additionally, GLP-1R agonists reduce visceral hypersensitivity and ameliorate symptoms in patients with irritable bowel syndrome
